Z-0673-2019 Class II Terminated
FDA device recall Z-0673-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 24083 units.
Recall details
- Product Type
- Devices
- Report Date
- Jan 2, 2019
- Initiation Date
- Nov 30, 2018
- Termination Date
- Jan 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24083 units
Product description
ST AIA-PACK FT3 (FT3: Free Triiodothyronine) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Free Triiodothyronine (FT3) in human serum or heparinized plasma on specific Tosoh AIA System analyzers.
Distribution pattern
US Nationwide
Code information
all lots
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0673-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026